Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace You Might Also Like The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine August 24, 2017 FDA Calls AstraZeneca PLC and MedImmune???s Imfinzi a Breakthrough July 30, 2017 KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly January 4, 2018
The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine August 24, 2017
KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly January 4, 2018
